

Principal Scientist with 17 years of experience in Biopharmaceutics and IVIVC modeling. Expertise in developing predictive models for bioequivalence and optimizing formulations for global regulatory submissions. Proven track record in strategic problem-solving and leadership, recognized with the CEO Award (2024) for excellence in science and innovation. Committed to utilizing advanced modeling tools and data analytics to enhance pharmaceutical development and patient outcomes.